Recurrent herpes labialis: current treatment perspectives.

Area of Science:

• Oral medicine
• Dermatology
• Infectious diseases

Background:

• Recurrent herpes simplex virus (HSV) infection of the lips and perioral skin is a prevalent condition impacting the general population.
• Patients frequently seek dental practitioners for diagnosis and treatment of these common oral and facial infections.
• Established mechanisms of viral reactivation underpin the development of therapeutic interventions.

Purpose of the Study:

• To review current therapeutic strategies for managing recurrent herpes simplex infections.
• To discuss treatment options considering patient immune status (healthy vs. immunocompromised).
• To provide an overview of both novel and traditional treatment modalities.

Main Methods:

• Literature review of existing scientific publications on herpes simplex virus (HSV) treatments.
• Analysis of clinical efficacy data for systemic and topical antiviral drugs.
• Categorization of treatments based on patient populations and therapeutic approaches.

Main Results:

• New classes of systemic and topical drugs demonstrate clinical effectiveness in reducing HSV recurrence frequency and duration.
• Treatment efficacy may vary between healthy and immunocompromised patient groups.
• Traditional therapies remain relevant options in the management of recurrent herpes simplex infections.

Conclusions:

• Effective pharmacological interventions are available for recurrent herpes simplex virus infections.
• Personalized treatment approaches are necessary, considering individual patient health and immune status.
• A comprehensive understanding of treatment choices aids dental practitioners in managing this common condition.